Virginia Calvo

4.0k total citations
87 papers, 1.1k citations indexed

About

Virginia Calvo is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Virginia Calvo has authored 87 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Oncology, 42 papers in Pulmonary and Respiratory Medicine and 20 papers in Cancer Research. Recurrent topics in Virginia Calvo's work include Lung Cancer Treatments and Mutations (29 papers), Lung Cancer Diagnosis and Treatment (21 papers) and Cancer Genomics and Diagnostics (16 papers). Virginia Calvo is often cited by papers focused on Lung Cancer Treatments and Mutations (29 papers), Lung Cancer Diagnosis and Treatment (21 papers) and Cancer Genomics and Diagnostics (16 papers). Virginia Calvo collaborates with scholars based in Spain, United States and United Kingdom. Virginia Calvo's co-authors include Mariano Provencio, Atocha Romero, Fernando Franco, Paloma Martín, Alberto Cruz‐Bermúdez, Aránzazu García‐Grande, María Torrente, Raquel Laza‐Briviesca, Sara Laine-Menéndez and Ramiro J. Vicente-Blanco and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

Virginia Calvo

81 papers receiving 1.1k citations

Peers

Virginia Calvo

ONCOL

PRM

PFM

Maristella Bianconi Italy

Lincoln Nadauld United States

Francisco Beça United States

Elisabetta Zulato Italy

Xiao‐Dong Jiao China

Liangliang Wu China

Ching Ouyang United States

Vincenzo Sforza Italy

Katsuhiro Anami Japan

Fuxiang Zhou China

Maristella Bianconi Italy

Virginia Calvo

558 ×1.2

ONCOL

402 ×0.9

416 ×1.1

375 ×1.0

PRM

110 ×0.8

PFM

Citations per year, relative to Virginia Calvo Virginia Calvo (= 1×) peers Maristella Bianconi

Countries citing papers authored by Virginia Calvo

Since Specialization

Citations

This map shows the geographic impact of Virginia Calvo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Virginia Calvo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Virginia Calvo more than expected).

Fields of papers citing papers by Virginia Calvo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Virginia Calvo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Virginia Calvo. The network helps show where Virginia Calvo may publish in the future.

Co-authorship network of co-authors of Virginia Calvo

This figure shows the co-authorship network connecting the top 25 collaborators of Virginia Calvo. A scholar is included among the top collaborators of Virginia Calvo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Virginia Calvo. Virginia Calvo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Serna‐Blasco, Roberto, J.L. González-Larriba, Reyes Bernabé, et al.. (2025). 210P: Prognostic Value of minimal residual disease in the NADIM II trial. Journal of Thoracic Oncology. 20(3). S138–S139. 1 indexed citations

Nadal, Ernest, Bartomeu Massutí, Aránzazu García‐Grande, et al.. (2025). Peripheral memory B cell population maintenance and long-term survival after perioperative chemoimmunotherapy in NSCLC (NADIM trial). OncoImmunology. 14(1). 2513109–2513109.

Calvo, Virginia, et al.. (2024). 1284P Clinical utility of liquid biopsy for non-small cell lung cancer patients with ALK fusion variants treated with brigatinib. Annals of Oncology. 35. S819–S819. 1 indexed citations

Calvo, Virginia, et al.. (2024). Quality of care assessment for non-small cell lung cancer patients: transforming routine care data into a continuous improvement system. Clinical & Translational Oncology. 27(3). 1047–1061. 1 indexed citations

Núñez, Beatriz, Juan Cristóbal Sánchez, Ana Royuela, et al.. (2023). Long‐term outcomes in Hodgkin lymphoma survivors. Temporary trends and comparison with general population. Hematological Oncology. 41(3). 407–414. 2 indexed citations

Torrente, María, Luca Costabello, Virginia Calvo, et al.. (2023). Machine Learning–Assisted Recurrence Prediction for Patients With Early-Stage Non–Small-Cell Lung Cancer. JCO Clinical Cancer Informatics. 7(7). e2200062–e2200062. 11 indexed citations

Calvo, Virginia, et al.. (2023). Spread through air spaces in non-small cell lung cancer: Experience of a tertiary hospital.. Journal of Clinical Oncology. 41(16_suppl). e20606–e20606. 1 indexed citations

Calvo, Virginia, Carlos Camps, Enric Carcereny, et al.. (2023). Difficulties on the access to innovative targeted therapies for lung cancer in Spain. Clinical & Translational Oncology. 26(3). 597–612. 3 indexed citations

García‐Grande, Aránzazu, et al.. (2023). Monitoring with circulating tumor cells in the perioperative setting of patients with surgically treated stages I–IIIA NSCLC. Translational Lung Cancer Research. 12(7). 1414–1424. 3 indexed citations

10.

Provencio, Mariano, Enric Carcereny, Rafael López Castro, et al.. (2023). Real-world treatment patterns and survival outcomes for patients with stage III non-small cell lung cancer in Spain: a nationwide cohort study. Translational Lung Cancer Research. 12(10). 2113–2128. 7 indexed citations

11.

Provencio, Mariano, Virginia Calvo, Atocha Romero, Jonathan Spicer, & Alberto Cruz‐Bermúdez. (2022). Treatment Sequencing in Resectable Lung Cancer: The Good and the Bad of Adjuvant Versus Neoadjuvant Therapy. American Society of Clinical Oncology Educational Book. 42(42). 711–728. 33 indexed citations

12.

Torrente, María, Pedro Sousa, Virginia Calvo, et al.. (2022). An Artificial Intelligence-Based Tool for Data Analysis and Prognosis in Cancer Patients: Results from the Clarify Study. Cancers. 14(16). 4041–4041. 25 indexed citations

13.

Llanos, Marta, Fernando Franco, Sagrario Gómez, et al.. (2022). Monitoring of Circulating Tumor DNA Predicts Response to Treatment and Early Progression in Follicular Lymphoma: Results of a Prospective Pilot Study. Clinical Cancer Research. 29(1). 209–220. 30 indexed citations

14.

Aix, Santiago Ponce, Enric Carcereny, Joaquim Bosch‐Barrera, et al.. (2021). 160P Pembrolizumab re-challenge in patients with relapsed non-small cell lung cancer (NSCLC): A preliminary report of the REPLAY phase II trial - cohort I. Annals of Oncology. 32. S1450–S1450. 5 indexed citations

15.

Franco, Fernando, M. Guirado, Natividad Martínez-Banaclocha, et al.. (2021). Multicenter Study of the Seroprevalence of Antibodies against Covid-19 in Patients with Lymphoma: An Analysis of the Oncological Group for the Treatment and Study of Lymphomas (Gotel). Current Oncology. 28(2). 1249–1255. 1 indexed citations

16.

Mielgo-Rubio, Xabier, M. Martín, Jordi Remón, et al.. (2021). Targeted Therapy Moves to Earlier Stages of Non-Small-Cell Lung Cancer: Emerging Evidence, Controversies and Future Challenges. Future Oncology. 17(30). 4011–4025. 16 indexed citations

17.

Calvo, Virginia, Ana Fernández‐Cruz, Beatriz Núñez, et al.. (2021). Cancer and SARS-CoV-2 Infection: A Third-Level Hospital Experience. Clinical Epidemiology. Volume 13. 317–324. 1 indexed citations

18.

Laza‐Briviesca, Raquel, et al.. (2020). Lung Cancer and COVID-19: Therapeutic Implications. 2(1). 1 indexed citations

19.

Mielgo-Rubio, Xabier, Virginia Calvo, J. Luna, et al.. (2020). Immunotherapy Moves to the Early-Stage Setting in Non-Small Cell Lung Cancer: Emerging Evidence and the Role of Biomarkers. Cancers. 12(11). 3459–3459. 9 indexed citations

20.

Cortés, Javier, Virginia Calvo, Natalia Ramírez-Merino, et al.. (2011). Adverse events risk associated with bevacizumab addition to breast cancer chemotherapy: a meta-analysis. Annals of Oncology. 23(5). 1130–1137. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact